Reimbursement and Regulatory Updates Impacting Home Health and Hospice Agency Value in 2025
Understanding how reimbursement and regulatory changes affect the value of your home health or hospice agency is crucial—especially heading into 2025. After a turbulent few years marked by payment model overhauls, pandemic policy waivers, and evolving quality benchmarks, agencies nationwide are now facing a new year of updates that will shape everything from margins to buyer interest. Here’s a clear look at what’s changing, what it means for your business, and how agency owners can respond to protect and grow their agency’s value.
8/14/20255 min read
What’s New for Hospice Agencies in 2025?
A Solid Payment Bump
If you operate a hospice agency, there’s good news on the reimbursement front: CMS finalized a 2.9% payment rate increase for the 2025 fiscal year[1]. This uptick is made up of a 3.4% market basket boost, trimmed back by a 0.5% productivity adjustment. While not earth-shattering, in the current environment, any positive trend is something to celebrate.
The Hospice Cap Rises
Each year, CMS sets a cap on aggregate hospice payments per patient, designed to curb overutilization. For 2025, that cap is $34,465.34, up from $33,494.01 in 2024[1]. Agencies with a high proportion of long-stay patients will want to keep an eye on this figure, since exceeding it could trigger clawbacks and require a strategy recalibration for patient mix and length of stay.
The HOPE Assessment Arrives
A major regulatory milestone is coming with the new Hospice Outcomes and Patient Evaluation (HOPE) assessment tool, going live for admissions starting October 1, 2025[1A]. HOPE is designed to standardize quality reporting and drive care improvements. While this will almost certainly boost transparency and benchmarking, it means agencies must budget for training, workflow changes, and extra time spent on documentation—not all of which translates to direct reimbursement.
Quality and Survey Updates
On top of HOPE, the Hospice Quality Reporting Program is getting a refresh, and the CAHPS Hospice Survey is seeing tweaks too. Agencies that score highly in these areas could see reputational benefits and improved purchasing interest, as buyers increasingly use quality metrics as due diligence filters.
Big Changes for Home Health in 2025
Market Basket + Behavioral Adjustment = Modest Net Gain
For home health agencies, it’s a more nuanced picture. CMS’s 2025 update brings a market basket increase of 2.7% (which accounts for inflation), but this is mostly offset by a permanent behavioral adjustment decrease of -1.975%[3][4]. The net? Home health providers get a slim 0.5% increase—roughly $85 million in extra Medicare payments across the industry, pushing the base 30-day payment rate to $2,057.35[3].
What’s driving the cuts? The ongoing implementation of the Patient-Driven Groupings Model (PDGM) and CMS’s efforts to align reimbursement with actual agency behavior. The “behavioral adjustment” reduces payments to account for what CMS views as coding and operational shifts agencies made to maximize revenue under PDGM[5]. The debate continues on whether these adjustments are fair, but the takeaway is clear—budgeting for razor-thin growth is the new normal.
Quality Reporting Gets a New Look
The Home Health Quality Reporting Program (HHQRP) is also evolving. While COVID-specific reporting has been replaced, agencies now must provide data on a broader suite of acute respiratory illnesses[4]. Expect more focus on outcomes and health equity as CMS attempts to align incentives with value and patient experience.
Value-Based Purchasing Adds Equity
The Home Health Value-Based Purchasing (HHVBP) Model continues to expand, and in 2025 will integrate health equity factors directly into performance calculations[3]. This means agencies serving higher-need or disadvantaged populations could see financial upside or downside depending on new quality and outcome scores.
New Standards to Combat Fraud
Another notable regulatory change: CMS will streamline the reactivation of Medicare billing privileges to help root out fraud and abuse[4]. The upshot for legitimate agencies? There may be new hoops to jump through if you deactivate/reactivate billing privileges, but the industry as a whole could benefit from a smaller pool of unreliable players.
What Sellers and Owners Need to Know
Valuations: Hospice Stronger Than Home Health?
It’s clear that valuation trends in 2025 will diverge between hospice and home health sectors, largely defined by these reimbursement updates:
Hospice agencies benefit from a healthy rate increase and a relatively straightforward regulatory environment. These factors, combined with a growing need for palliative and end-of-life care, could support strong valuations and buyer demand.
Home health agencies, on the other hand, must contend with ongoing behavioral adjustments and limited real growth. With labor costs rising and inflationary pressures squeezing margins, agencies that can demonstrate efficient operations and top-tier quality scores will stand out to buyers, while those with thin or negative margins will face increased scrutiny.
The Impact of Quality—and Compliance
Whether you’re preparing for sale, bringing on partners, or just aiming to compete, the regulatory bar is rising:
Quality reporting updates mean buyers are even more attracted to agencies with consistently high scores, robust compliance frameworks, and a proactive stance toward health equity.
Compliance costs (from HOPE, HHQRP, and new survey tools) will require more admin time, documentation, and possibly new tech investments. Agencies that already run lean, transparent, and compliant operations will have a leg up not just in regulatory survival, but in valuation as well.
Action Steps for Agencies in 2025
So, how can smart owners lean in and get ahead of the curve this year?
1. Invest in Training and Tech
Prepare early for HOPE and HHQRP updates—don't let workflow or documentation slow down patient care. Consider digital platforms for data capture, analytics, and compliance monitoring.
2. Audit Your Quality Scores
Benchmark your outcomes and survey results now. Use state and national averages as a guide, and close any lagging gaps proactively. If you aim to sell, this could be a major differentiator
3. Plan for Margin Tightness
Hospice agencies should factor the new payment cap into their budgets and forecasts. Home health agencies need to plan for minimal reimbursement growth and rising staff costs—every efficiency counts.
4. Leverage Health Equity Initiatives
Embrace equity-related performance metrics, both for compliance and potential bonus opportunities. This forward-thinking approach also appeals to modern buyers and payers.
5. Consult with Experts
It’s a lot to keep tabs on. If you're weighing a sale or partnership, seek out experienced healthcare M&A advisors who understand not just the math, but the operational nuances that drive 2025 valuations. Senate Healthcare offers consultations to help you clarify your value and options—schedule one here.
Final Thoughts
The regulatory landscape in 2025 rewards agencies that are proactive, data-savvy, and compliance-minded. Whether you’re in home health or hospice, adapting quickly to these changes isn’t just about surviving audits—it’s about making your agency more attractive to buyers, more resilient in tight operating conditions, and ultimately more valuable, whatever the next few years bring.
Have questions or want a deeper dive on how these trends affect you? Contact Senate Healthcare’s experts for guidance tailored to your agency’s size, market, and goals.
Want more healthcare M&A and strategy insights? Check out Care Network News for the latest at Senate Healthcare.
Unlock Your 30-Minute Agency Succession Review
Maybe you're ready to expand your reach, or perhaps it's time to consider your legacy and the future of your business. Either way, it all begins with a conversation. Schedule a confidential, no-obligation call to explore what the future might hold for you and your business.
Complete the form, and we'll reach out for a chat...
© 2025 SENATE HEALTHCARE LLC.
ALL RIGHTS RESERVED
